Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T2DM”

879 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 879 results

Large-scale testing (Phase 3)UnknownNCT03811548
What this trial is testing

Janagliflozin Treat T2DM Monotherapy

Who this might be right for
Diabetes Type 2
Sihuan Pharmaceutical Holdings Group Ltd. 442
Not applicableActive Not RecruitingNCT06445335
What this trial is testing

Prevalence of NAFLD in T2DM Patients

Who this might be right for
NAFLDT2DType 2 Diabetes+1 more
Ziekenhuis Oost-Limburg 385
Large-scale testing (Phase 3)Study completedNCT03173391
What this trial is testing

Long-term Efficacy and Safety of HMS5552 in T2DM Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Hua Medicine Limited 463
Testing effectiveness (Phase 2)Ended earlyNCT05761301
What this trial is testing

Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Alnylam Pharmaceuticals 49
Not applicableStudy completedNCT02805543
What this trial is testing

The Correlation Between the Retrobulbar Hemodynamics and Intrarenal Hemodynamics in T2DM Patients During the Early Period

Who this might be right for
Diabetes Mellitus, Type 2
Fourth People's Hospital of Shenyang 66
Very early researchStudy completedNCT02289235
What this trial is testing

Effects of Ginger on Nonalcoholic Fatty Liver Disease in T2DM

Who this might be right for
Fatty LiverDiabetes Mellitus, Type 2
Shiraz University of Medical Sciences 76
Early research (Phase 1)Ended earlyNCT01923389
What this trial is testing

Multiple Dose Study Of PF-05231023 In Obese Adult Subjects

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Pfizer 4
Early research (Phase 1)Study completedNCT05294458
What this trial is testing

A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Who this might be right for
Non-alcoholic SteatohepatitisType 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
AstraZeneca 10
Post-approval studies (Phase 4)Study completedNCT02325960
What this trial is testing

A Comparison of Exenatide and Insulin Glargine

Who this might be right for
Type 2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44
Large-scale testing (Phase 3)Active Not RecruitingNCT05505994
What this trial is testing

The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders+2 more
Daewoong Pharmaceutical Co. LTD. 340
Not applicableStudy completedNCT07183137
What this trial is testing

Metabolic Surgery for Metabolic Syndrome

Who this might be right for
Metabolic Syndrome (MetS)Hypertension (HTN)Obesity+4 more
The Third Xiangya Hospital of Central South University 1,581
Early research (Phase 1)Study completedNCT06333977
What this trial is testing

LC542019 in Healthy Subjects and Subjects With T2DM

Who this might be right for
HealthyDiabetes Mellitus, Type 2
LG Chem 100
Post-approval studies (Phase 4)UnknownNCT01718457
What this trial is testing

Endobarrier Treatment in Obese Subjects With T2DM

Who this might be right for
Type 2 DiabetesObesity
Sheba Medical Center 45
Early research (Phase 1)Study completedNCT03414736
What this trial is testing

A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 60
Large-scale testing (Phase 3)Ended earlyNCT00430742
What this trial is testing

An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)

Who this might be right for
Obesity Type 2 Diabetes MellitusType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 600
Post-approval studies (Phase 4)Study completedNCT02694263
What this trial is testing

Canagliflozin (Invokana™) vs. Standard Dual Therapy Regimen for T2DM During Ramadan

Who this might be right for
Diabetes Mellitus, Type 2
University of Leicester 25
Post-approval studies (Phase 4)Study completedNCT01779609
What this trial is testing

ET-blockade and Exercise-induced Vascular Adaptations in T2DM

Who this might be right for
Type 2 Diabetes Mellitus
Radboud University Medical Center 19
Not applicableStudy completedNCT07383532
What this trial is testing

Effects of Education and Telephone Support on Type 2 Diabetes Management

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Selcuk University 70
Not applicableStudy completedNCT05943899
What this trial is testing

Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis

Who this might be right for
Type2diabetes
Diabetes Foundation, India 60
Post-approval studies (Phase 4)Looking for participantsNCT07019012
What this trial is testing

Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.

Who this might be right for
T2DM
Huazhong University of Science and Technology 170
Load More Results